BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
PRINCIPAL INVESTORS: Ben Franklin Technology Partners
BUSINESS STRATEGY: Discover, develops, manufacture and market important protein expression
technologies based on advances in cellular and molecular biology
Market to academic and government research institutions, and
pharmaceutical and biotechnology companies worldwide in efforts to
improve the quality of human life
AGREEMENTS: Name Products Content of Agreement Date
Embrex Inc. development of a three-year
1/00
sensor for the poultry
gender sorting market
agreement
Rohm & Haas Co. development of insect research
12/96
receptor based
screening technology
collabration
RESEARCH & DEVELOPMENT: Protein expression and biosensors utilizing the benefits of SUMO
PRODUCTS ON MARKET: SUMOpro Expression System
Split SUMOpro Expression System
Fusion controls
Proteases
Expression vectors
Prokaryotic, yeast and insect expression kits
PRODUCTS IN DEVELOPMENT: Name Status
Estrogen detection biosensor development stage
2nd Generation SUMO Expression
Systems
development stage
Link Technologies Ltd.
3 Mallard Way, Strathclyde Business Park
Bellshill ML4 3BF, UK
Phone: +44 (0) 1698-849911; Fax: +44 (0) 1698-849922
Web: www.linktech.co.uk
E-mail: enquiries@linktech.co.uk
KEY PERSONNEL: Jim Fisher; Chairman
Dr. Michael Gray; Managing Director
Dr. Douglas Picken; Director, R&D
Dr. John Bremner; Director, Business Development
EMPLOYEES: 20 employees
HISTORY: Founded in January 1987
Began biotech R&D in May 1989
FACILITIES: 7,000 sq. ft. laboratory, office and warehouse facility
STOCK-FINANCIAL HISTORY: Privately held
RESEARCH & DEVELOPMENT: Nonradioactive labeling of oligonucleotides
Antisense DNA reagents
Base-modified nucleotides
Biomolecule conjugation
PRODUCTS ON MARKET: Range of reagents for DNA synthesis
Supported reagents for large-scale synthesis
Copyright ©2006 AHC Media ® 226